EXACT Therapeutics Doses First Patient in Pancreatic Cancer Trial
June 24, 2025
EXACT Therapeutics, a clinical-stage precision medicine company, is pleased to announce first patient dosed in its ENACT trial. The trial is a multi-centre, open-label Phase